Search PubMed⌕ Search

Biomedical subjects

A Zimmermann

Publications and source records attributed to A Zimmermann.

At least 415 records · Page 23Linked to original sources

Non-Hodgkin's lymphoma terminating in acute myelogenous leukemia.

The number of patients with non-Hodgkin's lymphoma who develop acute myelogenous leukemia is relatively small. The case of a patient with histologically proven diffuse histiocytic lymphoma who died with unequivocal acute myelogenous leukemia 5 years after the lymphoma diagnosis is presented. The difficulties in differential diagnosis are cited with a review of the literature.

Aged↗

[Bladder carcinoma associated with long-term treatment with cyclophosphamide for multiple myeloma (author's transl)].

A report is presented of a female patient who developed an extensive bladder carcinoma with severe hemorrhaging after many years of treatment with cyclophosphamide for multiple myeloma. The severe hemorrhage could only be controlled by drainage of the urine. The possible causes of the development of a second neoplasia, particularly of urinary bladder carcinoma following long-term therapy with cyclophosphamide, are discussed.

Aged↗

Protein-losing enteropathy due to segmental erosive and ulcerative intestinal disease cured by limited resection of the bowel.

Two children suffering from extensive intestinal protein loss due to subacute and chronic segmental small bowel disease are presented. In the first case a tentative diagnosis of chronic erosive and ulcerative non-granulomatous jejunitis as described in adults was made. The second child suffered from subacute erosive and ulcerative segmental transmural ileitis following mechanical ileus. In both instances resection of the involved segments of small intestine promptly cured the enteric protein loss. It is suggested that excessive protein loss due to subacute or chronic segmental erosive and ulcerative intestinal disease may be cured definitively by surgical resection. An explorative laparotomy should be performed if broad internistic investigations do not provide an explanation for the severe and prolonged enteric protein loss.

Adolescent↗

[Comparative cytologic and flow-through cytophotometric studies in prostate cells (author's transl)].

Concerning the content of DNA, there are significant differences between nuclei of cells from the adenoma and those from the carcinoma of the prostate. As it is possible to measure these differences by using flow-through cytophotometry, this method might also be capable of automatizing the cytology of this organ. In a clinical study, the results of cytologic examinations and flow-through cytophotometric tests of the prostate are compared. They are comparable in the case of benign diseases of the prostate. In carcinomas of the prostate, cytology gives more positive results than flow-through cytophotometry. An improvement of these findings seems possible through the technical amendment of the method. The number of probes that can not be interpreted are fewer with flow-through cytophotometry than with cytology.

Computers↗

[Interstial pneumopathy after low dose bleomycin therapy].

The case is report of a 52-year-old woman who died of interstitial pneumopathy following treatment for an unclassifiable neoplasm of liver, spleen and bone marrow with a total dose of 97 mg/m2 bleomycin. The development of interstitial pneumopathy after this low bleomycin dosage may have been favored by a previous thorax irradiation 22 years earler for round cell sarcoma.

Bleomycin↗

Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma.

Histological changes in tracheobronchial and bronchopulmonary lymph nodes of patients with operable (i.e. stages T1/2, N0/1, M0) bronchogenic squamous cell carcinoma were examined histometrically. Out of 29 patients, 10 survived less than 12 months and 19 lived longer than two years after surgery. Quantitative methods were employed for measuring structural changes in lymph node sections at the histological and cellular level. The following parameters reflecting both cellular and humoral immune responses correlated with survival: relative numbers of large lymphoid cells and mitotic figures in the paracortical ("thymus-dependent") area; volume of the follicular (predominantly B-cell) cortex; and volume of germinal centers. Pronounced accumulation of histiocytes or dust-loaded macrophages in the paracortex and presence of "empty" lymph sinusoids (i.e. without sinuhistiocytosis) correlated inversely with survival. In addition to the theoretical importance and considerations of a documented immune response, such data could help in identifying high risk groups within the same stage of bronchogenic carcinoma of a given type.

Carcinoma, Bronchogenic↗

[Studies on the effect of drugs on somatosensory cortical evoked potentials (author's transl)].

The effect of the following drugs in therapeutic doses on somatosensory cortical evoked potentials was studied: methamphetamine, chlorpromazine, imipramine, diazepam, phenobarbital, pethidine, and novaminesulfone. Physiological saline was used as control. Each of these compounds was studied in 5 healthy subjects. Three evoked potentials were recorded before, and another three after administration of the drug. Each potential was averaged from 1024 single stimuli. None of the drugs, led to marked changes of the evoked potential, i.e., all data (latencies, amplitudes) were within the double standard deviation of the data obtained in normal subjects in a previous study. Although no significant changes were seen, some trends could be observed: methamphetamine and imipramine produced a decrease in the latency of the first positive peak, chlorpromazine increased the latency of the third positive peak. The amplitude of the third peak was reduced under phenobarbital. It is concluded that the drugs investigated in the presents study do not produce significant changes in the somatosensory cortical evoked potential and therefore drug application may be continued when evoked potentials are used for diagnostic purposes.

Chlorpromazine↗

[Duodenal duplication. Case report and review of the literature].

A case of duodenal duplication (cyst) in a 42-year-old male is reported. The late manifestation of this rare, little-known, but noteworthy congenital malformation was characterized by repeated attacks of acute pancreatitis and development of a high, duodenal obstruction. Radiographic examination and fiberoptic endoscopy was followed by exploratory laparotomy which demonstrated the accurate diagnosis. A review of the literature including 39 duodenal duplications in more than 300 duplications of the alimentary tract is presented.

Adult↗

[Correlation between immuno-morphological parameters of regional lymph nodes and the mortality of patients with stage I and II bronchial squamos cell carcinoma].

Histological changes in tracheobronchial and bronchopulmonary lymph nodes of patients with operable (i.e. stages T 0/2, N 0/1, M0) bronchogenic squamous cell carcinoma were examined histometrically. Out of 29 patients 10 survived less than 12 months and 19 lived longer than two years after surgery. Quantitive methods were employed for measuring structural changes in lymph node sections at the histological and cellular level. The following parameters reflecting both cellular and humoral immune responses correlated with survival: relative numbers of large lymphoid cells and mitotic figures in the paracortical "thymus dependent") area; volume of the follicular (predominantly B-cell) cortex and volume of germinal centers. Pronounced accumulation of histiocytes or dust-loaded marcrophages in the paracortex and presence of "empty" lymph sinusoids (i.e. without sinushistiocytosis) correlated inversely with survival. Besides the theoretical importance and considerations of a documented immune response, such data could help in identifying high risk groups within the same stage of bronchogenic carcinoma of a given type.

Carcinoma, Bronchogenic↗

[Functional lymph node diagnosis].

This short review focuses on recent developments in the field of functional morphology of peripheral lymphoid tissues, in particular of lymph nodes. Emphasis is given to cellular and histological characteristics of lymph nodes in the course of cell-mediated and humoral immune responses. Against the background of regional and age-related changes, selected examples of a functional interpretation of structural changes are presented.

Humans↗

Nervous system antigen-5, an antigenic cell surface component of neuroectodermal origin.

The antigenic cell surface component NS-5 (nervous system antigen-5) is recognized by antiserum raised in C3H.SW/Sn mice against cerebellum of 4-day-old C57BL/6J mice. When analyzed in the cytotoxicity test the antiserum detects a cell surface antigen or set of antigens present not only an cerebellum but also other parts of the central nervous system, including retina, as well as on mature spermatozoa and to a lesser degree on kidney. All other non-neural tissues tested, liver, splee, thymocytes, muscle, testis, adrenal gland and epidermis do not express detectable amounts of the antigen. Among seven murine tumors of the nervous system, medulloepithelioma shows high levels of NS-5 expression, whereas neuroblastoma Cl300, glioma G26, glioblastome, ependymoblastoma, ependymoblastoma EPA and glioblastoma G26l do not carry detectable NS-5. All mouse strains tested (C57BL/6J, C3H.SW/Sn, C3H/HeDiSn, A/J, AKR/J, BALB/cJ and DBA/2) express similar levels of NS-5. The antigen is demonstrable not only on postnatal day 4 neural tissue, but also in lower amounts on adult nervous system. On embryonic day 9, the earliest stage tested, and at all subsequent stages during embryonic development, NS-K is already present in brain and spinal cord, but not in gut.

Age Factors↗

Central nervous system antigen (NS-5) and its presence during murine ontogenesis.

An antiserum raised by immunization of C3H.SW/Sn mice with cerebellum from 4-day-old C57BL/6J mice recognizes a cell surface component(s) [NS-5] present in different degrees on various parts of the mouse central nervous system. When analyzed by an antiserum- and complement-mediated cell cytotoxicity test and by the ability of various tissuesto absorb anti-NS-5 antiserum activity, the antigen(s) was detectable on cerebellum, retina, olfactory bulb, cortex, basal ganglia, and medulla but not on nonneural tissues with the exception of mature spermatozoa and 4-day-old kidney. The antigen(s) detected by the anti-NS-5 antiserum was found in similar quantities on young and adult rat and mouse cerebellum; however, it was not detectable on any of 16 clonal cell lines derived from the rat central nervous system. During preimplantation stages of murine development, the antigen could be detected on all cells of (2-4)-cell and (8-16)-cell stages and on the trophoblastic cells of blastocysts by indirect immunofluorescence, Embryos on day 9 of gestation, the earliest tested after implantation, expressed the antigen(s), but expression was restricted to the nervous system.

Animals↗

Problems relating to immunoselection of leukemias.

Problems relating to immunoselection of neoplastic, in particular leukemic, cell lines are reviewed. Since there is ample evidence that specific immune reactions of the host against malignant neoplastic cells do occur, it becomes important to consider the effectiveness and the relevance of immunity in suppression or elimination of neoplastic growth. Emphasis is placed on experimental results obtained in syngeneic tumor-host combinations, because they more closely resemble the situation of spontaneous tumorigenesis or leukemogenesis than xenogeneic or allogeneic model systems. Studies of types of neoplasia observed in cases of human immunodeficiency syndromes offer an important insight into problems involved in immunoselection of leukemic cell lines: the marked predominance of leukemias and lymphoreticular neoplasias in immunodeficient patients invites speculation on both the mechanisms of leukemogenesis and the relative importance of the immune system in eliminating malignant neoplastic cells.

Animals↗